874758-54-0

Basic information

• Product Name: 1,3-Benzodioxole-4-acetic acid, α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]-, ethyl ester
• Synonyms: 1,3-Benzodioxole-4-acetic acid, α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]-, ethyl ester;Ethyl 2-hydroxy-2-(6-(methoxymethoxy)-7-(((trifluoromethyl)sulfonyl)oxy)benzo[d][1,3]dioxol-4-yl)acetate
• CAS NO: 874758-54-0
• Molecular Formula: C₁₄H₁₅F₃O₁₀S
• Molecular Weight: 432.3231096
• Mol File: 874758-54-0.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-Benzodioxole-4-acetic acid, α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzodioxole-4-acetic acid, α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]-, ethyl ester(874758-54-0)
• EPA Substance Registry System: 1,3-Benzodioxole-4-acetic acid, α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]-, ethyl ester(874758-54-0)

Safety Data

• Hazardous Substances Data: 874758-54-0(Hazardous Substances Data)

Usage

Chemical class

Ester derivative

Explanation

The compound is an ester derivative of 1,3-Benzodioxole-4-acetic acid, which means it has an ester functional group attached to the parent compound.

Explanation

The parent compound, 1,3-Benzodioxole-4-acetic acid, has potential therapeutic applications in reducing inflammation and providing pain relief.

Explanation

The ethyl ester form of the compound may have improved characteristics or bioavailability compared to the parent compound, which could be beneficial for pharmaceutical applications.

Explanation

The addition of this specific group to the molecule may confer unique chemical properties or interactions that could be useful in various applications, such as pharmaceutical or industrial.

Explanation

The lengthy and complicated name of the compound indicates its potential significance in the fields of chemistry and pharmacology, suggesting that it may have unique or important properties.

Explanation

Due to its unique properties and modifications, the compound may be useful in the development of new drugs or in various industrial processes.

Therapeutic applications

Anti-inflammatory and analgesic properties

Enhanced characteristics

Ethyl ester form

Chemical modification

α-hydroxy-6-(methoxymethoxy)-7-[[(trifluoromethyl)sulfonyl]oxy]group

Complex nature

Long and detailed name

Molecular structure

Contains a benzodioxole ring, an acetic acid group, an ethyl ester group, and a trifluoromethylsulfonyl group

Potential use

Pharmaceutical or industrial applications

Upstream product

• 874758-53-9 hydroxy-(7-hydroxy-6-methoxymethoxy-benzo[1,3]dioxol-4-yl)-acetic acid ethyl ester 
• 17763-80-3 para-nitrophenyl triflate 
• 533-31-3 Sesamol 
• 111726-43-3 3,4-(methylenedioxy)phenyl methoxymethyl ether 
• 244126-41-8 4-hydroxy-5-(methoxymethoxy)-1,3-benzodioxole 

Downstream Products

• 874758-69-7 C₆₀H₆₁Cl₃N₄O₁₅S 
• 114899-77-3 ecteinascidin 743 
• 114899-80-8 (1'R,6R,6aR,7R,13S,14R,16R)-5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8-dihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinoline]-14-carbonitrile 

Relevant articles and documents

Intermediate and process of preparation of ecteinascidin using such intermediate

The present invention concerns an intermediate of the following formula I in which R1 and R2 represent independently of each other a C1-C12 alkyl group, a (C1-C12 alkoxy)carbonyl group, opt